Short answer
Paysign, Inc. (PAYS) filed its Q1 2026 10-Q quarterly report on May 13, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $28M (up 50.8% year over year) with net income of $5M.
Q1 2026 key financials · XBRL
- Revenue
- $28M
- +50.8% YoY
- Net income
- $5M
- +110.3% YoY
- Operating margin
- 23.8%
- Gross margin
- 65.0%
- EPS (diluted)
- $0.09
- +80.0% YoY
Source: XBRL data from the Paysign, Inc. (PAYS) Q1 2026 10-Q on SEC EDGAR. USD.
Paysign, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $28.0M, up 50.8% YoY from $18.6M
- Pharma revenue $15.7M, up 81.9% YoY; plasma revenue $11.7M, up 24.9%
- Gross margin 65.0% vs 62.9%; net margin 19.4% vs 13.9% YoY
- Operating cash flow $18.8M vs $(6.0)M; cash and restricted cash increased $14.5M
- 2026 investment focus: technology, sales, cybersecurity, fraud, customer service, and regulatory compliance
Risk Factors
- No risk-factor updates; Paysign, Inc. omitted Item 1A as a smaller reporting company
- Repurchase-program execution risk; original $5 million authorization expired March 20, 2026
- Capital-allocation flexibility; $3,001,285 remained available under the original program at March 31, 2026
- New buyback authorization risk; May 8, 2026 program permits up to $5 million through May 7, 2029
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Paysign, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.